Related Experiment Videos
Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine (MPTP) on ganglionic transmission
1Department of Pharmacology, College of Pharmacy, University of Houston, Texas 77204-5515.
Abstract:
1. The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine (MPTP) caused blockade of ganglionic transmission as evidenced by a marked decrease of the amplitude of evoked post-ganglionic compound action potential of the isolated superior cervical ganglion of rat. 2. This effect was not related to its dopaminergic neurotoxicity since pretreatment with pargyline did not prevent the ganglion-blocking action of MPTP. The effects of MPTP on ganglionic transmission were qualitatively similar to those of its narcotic analgesic analogue meperidine. The effects of both drugs were antagonized by the narcotic antagonist naloxone, indicating that the ganglion-blocking effect of MPTP also involved opiate receptors. 3. Like meperidine and morphine, the ganglion-blocking action of MPTP was reduced when the concentration of Ca2+ in the Locke solution was elevated. The blocking effect of methadone on transmission was not reduced by naloxone or elevated Ca2+. 4. The effect of MPTP on nerve action potential was minimal, indicating that the drug blocked synaptic transmission in the ganglion. 5. These results suggest that MPTP inhibits synaptic transmission in the isolated superior cervical ganglion of the rat, probably by interfering with Ca2+ function.
Insights
The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine (MPTP) blocks nerve signal transmission in rat superior cervical ganglia, acting via opiate receptors and calcium ion interference, not dopaminergic toxicity.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine (MPTP) is known for its dopaminergic neurotoxicity.
- Its effects on ganglionic transmission are less understood.
Purpose of the Study:
- To investigate the mechanism by which MPTP affects ganglionic transmission.
- To determine if MPTP's action involves opiate receptors or calcium ion channels.
Main Methods:
- Isolated rat superior cervical ganglion preparation.
- Electrophysiological recording of post-ganglionic compound action potentials.
- Administration of MPTP, meperidine, methadone, pargyline, and naloxone.
- Manipulation of extracellular calcium ion concentration.
Main Results:
- MPTP caused a significant blockade of ganglionic transmission.
- This effect was not prevented by pargyline, indicating it's independent of dopaminergic neurotoxicity.
- MPTP's action was antagonized by naloxone and reduced by elevated Ca2+, suggesting opiate receptor involvement and interference with calcium function.
- MPTP primarily blocked synaptic transmission rather than nerve action potentials.
Conclusions:
- MPTP inhibits synaptic transmission in the superior cervical ganglion.
- The mechanism likely involves interaction with opiate receptors and interference with calcium ion (Ca2+) function.
- MPTP's ganglionic effects differ from methadone, which was unaffected by naloxone or elevated Ca2+.